* Merit Medical Systems Inc MMSI.OQ MMSI.O is expected
to show
a rise in quarterly revenue when it reports results on July
25.
* The South Jordan Utah-based company is expected to report
a
5.2% increase in revenue to $310.447 million from $294.98
million a year ago, according to the mean estimate from 7
analysts, based on Refinitiv data. The company's guidance on
April 26 2023, for the period ended June 30, was for revenue
between $306.78 million and $312.67 million.
* Refinitiv's mean analyst estimate for Merit Medical
Systems Inc
is for earnings of 75 cents per share. The company's EPS
guidance on April 26 2023, for the period ended June 30, was
between $0.73 and $0.77
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 6 "strong buy" or "buy," 2
"hold" and no "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for Merit
Medical
Systems Inc is $92.5, above its last closing price of $81.96.
The company's guidance on April 26 2023 for the period ended
June 30 was for gross profit margin between USD46.48% and
USD47.08%.
Previous quarterly performance (using preferred earnings measure
in US dollars).
QUARTER STARMINESM REFINITIV ACTUAL BEAT, SURPRI
ENDING ARTESTIMAT IBES MET, SE %
E® ESTIMATE MISSED
Mar. 31 2023 0.55 0.55 0.64 Beat 17.2
Dec. 31 2023 0.67 0.67 0.79 Beat 17.7
Sep. 30 2022 0.53 0.53 0.64 Beat 21.1
Jun. 30 2022 0.58 0.58 0.73 Beat 26.3
Mar. 0.47 0.47 0.53 Beat 13.9
31 2022
Dec. 31 2021 0.51 0.52 0.71 Beat 36.5
Sep. 30 2021 0.44 0.44 0.52 Beat 19.2
Jun. 30 2021 0.45 0.44 0.62 Beat 39.7
This summary was machine generated July 21 at 21:41 GMT. All
figures in US dollars unless otherwise stated